Skip to main content

Fosaprepitant

NDC 68001-675 · BluePoint Laboratories

Generic nameFosaprepitant
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)FOSAPREPITANT DIMEGLUMINE
Strength150 mg/5mL
Pharmacologic classCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

68001-675-25 — 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-675-25) / 5 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J1453 — Injection, fosaprepitant, 1 mg Medicare Part B payment limit (ASP + 6%): $0.11

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-165 — Fosaprepitant dimeglumine, 43598-671 — Fosaprepitant, 43598-859 — Fosaprepitant, 43598-948 — Fosaprepitant, 55150-299 — FOSAPREPITANT DIMEGLUMINE, 63323-972 — FOSAPREPITANT, 67184-0540 — FOSAPREPITANT DIMEGLUMINE, 67457-889 — fosaprepitant, 68001-421 — Fosaprepitant, 68001-523 — Fosaprepitant dimeglumine, 70121-2631 — FOSAPREPITANT DIMEGLUMINE, 71731-5111 — FOSAPREPITANT DIMEGLUMINE, 71839-104 — fosaprepitant, 72162-2636 — Fosaprepitant, 72205-054 — Fosaprepitant, 72205-083 — Fosaprepitant, 72603-450 — Fosaprepitant, 82449-231 — FOSAPREPITANT DIMEGLUMINE, 83634-776 — fosaprepitant dimeglumine, 83831-153 — fosaprepitant, +6 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources